JUST IN: NAFDAC Approves Use Of AstraZenaca COVID-19 Vaccine
On Thursday, the National Agency for Food and Drug Administration and Control approved the use of AstraZeneca Vaccine in Nigeria.
NAFDAC Director-General, Prof. Mojisola Adeyeye, disclosed the approval at a press conference in Abuja.
Adeyeye noted that the agency got the dossier of the vaccine a week ago and immediately evaluated the safety and its efficacy which came out positive.
According to her, the evaluation of AstraZeneca has proven its efficacy to fight against the United Kingdom variant of the virus which had been reported in Nigeria.
She explained that the vaccine can be stored in two to eight degrees centigrade, adding that three other vaccine types were undergoing evaluation.
Adeyeye mentioned that although the South African variant had not been reported in Nigeria, there are over 30 herbal medicines undergoing review for listing.
The World Health Organisation (WHO) had recently approved AstraZeneca vaccine for emergency use to curtail the spread of COVID-19.